Compounds
US9242972B2 · kind B2 · utility
5Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2013 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Apr 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.